3.0.0 33 2025-05-27T14:15:42Z 2025-05-27T14:15:42Z Senate S S 2023-01-24 118 ssfi00 Finance Committee Senate Standing Referred To 2023-01-24T16:58:57Z 2023-01-24 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2023-01-24 Introduced in Senate IntroReferral 10000 9 Library of Congress R000595 Sen. Rubio, Marco [R-FL] Marco Rubio R FL N Taxation Aging 2023-03-15T14:15:20Z Business expenses 2023-03-15T14:15:20Z Business investment and capital 2023-03-15T14:15:20Z Cardiovascular and respiratory health 2023-03-15T14:15:20Z Community life and organization 2023-03-15T14:15:20Z Congressional oversight 2023-03-15T14:15:20Z Drug safety, medical device, and laboratory regulation 2023-03-15T14:15:20Z Economic development 2023-03-15T14:15:20Z Emergency medical services and trauma care 2023-03-15T14:15:20Z Government studies and investigations 2023-03-15T14:15:20Z Health technology, devices, supplies 2023-03-15T14:15:20Z Income tax credits 2023-03-15T14:15:20Z Income tax deductions 2023-03-15T14:15:20Z Industrial facilities 2023-03-15T14:15:20Z Infectious and parasitic diseases 2023-03-15T14:15:20Z Manufacturing 2023-03-15T14:15:20Z Minority health 2023-03-15T14:15:20Z Public-private cooperation 2023-03-15T14:15:20Z Research administration and funding 2023-03-15T14:15:19Z Research and development 2023-03-15T14:15:19Z Unemployment 2023-03-15T14:15:19Z Veterans' medical care 2023-03-15T14:15:20Z Wages and earnings 2023-03-15T14:15:20Z Taxation 2023-02-02T13:32:01Z

00 2023-01-24 Introduced in Senate 2023-02-02T13:24:47Z <p><b>Medical Manufacturing, Economic Development, and Sustainability Act of 2023 or the MMEDS Act of 2023</b></p> <p>This bill provides incentives for relocating medical manufacturing facilities in the United States and for manufacturing medical products (i.e., drugs and devices) in economically distressed zones. Specifically, the bill allows a income tax credit for 40% of the sum of wages paid in a medical product manufacturing economically distressed zone, employee fringe benefit expenses, and depreciation and amortization allowances with respect to qualified medical product manufacturing facility property, and a credit for economically distressed zone products and services acquired by domestic medical product manufacturers..</p> <p>The bill also directs the Department of Health and Human Services to study the extent to which the health of aging individuals and vulnerable populations have been disproportionately harmed by the COVID-19 (i.e., coronavirus disease 2019) pandemic and prior epidemics and pandemics.</p>

Display Title 45 2024-07-24T15:24:06Z Short Title(s) as Introduced 101 2024-05-24T13:43:00Z Introduced in Senate IS Short Title(s) as Introduced 101 2024-05-24T13:43:00Z Introduced in Senate IS Official Title as Introduced 6 2023-01-28T03:58:53Z Introduced in Senate IS Introduced in Senate 2023-01-24T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s33is/xml/BILLS-118s33is.xml 2023-01-24 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.